首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   19338篇
  免费   1618篇
  国内免费   37篇
耳鼻咽喉   126篇
儿科学   701篇
妇产科学   487篇
基础医学   2409篇
口腔科学   475篇
临床医学   2959篇
内科学   3538篇
皮肤病学   189篇
神经病学   1518篇
特种医学   546篇
外科学   2499篇
综合类   457篇
一般理论   20篇
预防医学   2363篇
眼科学   219篇
药学   1163篇
中国医学   9篇
肿瘤学   1315篇
  2021年   270篇
  2020年   181篇
  2019年   282篇
  2018年   359篇
  2017年   275篇
  2016年   288篇
  2015年   338篇
  2014年   485篇
  2013年   728篇
  2012年   1077篇
  2011年   1192篇
  2010年   616篇
  2009年   573篇
  2008年   1003篇
  2007年   1150篇
  2006年   1043篇
  2005年   1041篇
  2004年   981篇
  2003年   896篇
  2002年   897篇
  2001年   445篇
  2000年   517篇
  1999年   469篇
  1998年   180篇
  1997年   161篇
  1996年   181篇
  1995年   194篇
  1994年   168篇
  1993年   153篇
  1992年   340篇
  1991年   342篇
  1990年   356篇
  1989年   299篇
  1988年   265篇
  1987年   261篇
  1986年   242篇
  1985年   252篇
  1984年   184篇
  1983年   148篇
  1982年   105篇
  1980年   109篇
  1979年   155篇
  1978年   127篇
  1977年   102篇
  1976年   101篇
  1974年   124篇
  1973年   116篇
  1972年   117篇
  1971年   115篇
  1970年   104篇
排序方式: 共有10000条查询结果,搜索用时 390 毫秒
1.
Racial/ethnic identity is contingent and arbitrary, yet it is commonly used to evaluate disease risk and treatment response. Drawing on open-ended interviews with patients and clinicians in two US clinics, we explore how racialized risk is conceptualized and how it impacts patient care and experience. We found that racial/ethnic risk was a common but poorly defined construct for both patients and clinicians, who intermingled concepts of genetics, biology, behavior, and culture, while disregarding historical or structural context. We argue that racializing risk embodies social power in marked and unmarked bodies, reinforcing inequality along racial lines and undermining equitable health care.  相似文献   
2.
3.
4.
5.
6.

Background

We have recently shown that human epididymis protein 4 (HE4) levels correlate with the severity of cystic fibrosis (CF) lung disease. However, there are no data on how HE4 levels alter in patients receiving CFTR modulating therapy.

Methods

In this retrospective clinical study, 3 independent CF patient cohorts (US-American: 29, Australian: 12 and Irish: 19 cases) were enrolled carrying at least one Class III CFTR CF-causing mutation (p.Gly551Asp) and being treated with CFTR potentiator ivacaftor. Plasma HE4 was measured by immunoassay before treatment (baseline) and 1–6?months after commencement of ivacaftor, and were correlated with FEV1 (% predicted), sweat chloride, C-reactive protein (CRP) and body mass index (BMI).

Results

After 1?month of therapy, HE4 levels were significantly lower than at baseline and remained decreased up to 6?months. A significant inverse correlation between absolute and delta values of HE4 and FEV1 (r?=??0.5376; P?<?.001 and r?=??0.3285; P?<?.001), was retrospectively observed in pooled groups, including an independent association of HE4 with FEV1 by multiple regression analysis (β?=??0.57, P?=?.019). Substantial area under the receiver operating characteristic curve (ROC-AUC) value was determined for HE4 when 7% mean change of FEV1 (0.722 [95% CI 0.581–0.863]; P?=?.029) were used as classifier, especially in the first 2?months of treatment (0.806 [95% CI 0.665–0.947]; P?<?.001).

Conclusions

This study shows that plasma HE4 levels inversely correlate with lung function improvement in CF patients receiving ivacaftor. Overall, this potential biomarker may be of value for routine clinical and laboratory follow-up of CFTR modulating therapy.  相似文献   
7.
8.
We pooled multiethnic data from four population-based studies and examined associations of menstrual and reproductive characteristics with breast cancer (BC) risk by tumor hormone receptor (HR) status [defined by estrogen receptor (ER) and progesterone receptor (PR)]. We estimated odds ratios and 95% confidence intervals using multivariable logistic regression, stratified by age (<50, ≥50 years) and ethnicity, for 5,186 HR+ (ER+ or PR+) cases, 1,365 HR− (ER− and PR−) cases and 7,480 controls. For HR+ BC, later menarche and earlier menopause were associated with lower risk in non-Hispanic whites (NHWs) and Hispanics, and higher parity and longer breast-feeding were associated with lower risk in Hispanics and Asian Americans, and suggestively in NHWs. Positive associations with later first full-term pregnancy (FTP), longer interval between menarche and first FTP and shorter time since last FTP were limited to younger Hispanics and Asian Americans. Except for nulliparity, reproductive characteristics were not associated with risk in African Americans. For HR− BC, lower risk was associated with later menarche, except in African Americans and older Asian Americans and with longer breast-feeding in Hispanics and Asian Americans only. In younger African Americans, HR− BC risk associated with higher parity (≥3 vs. 1 FTP) was increased fourfold in women who never breast-fed, but not in those with a breast-feeding history, suggesting that breast-feeding may mitigate the adverse effect of higher parity in younger African American women. Further work needs to evaluate why menstrual and reproductive risk factors vary in importance according to age and ethnicity.  相似文献   
9.
10.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号